Illumina partners with Sanigen to help NGS platform technology penetrate South Korean market

U.S – Sanigen, a South Korean-based molecular diagnostics and bioinformatics company, has announced that it will become a channel partner (distributor) in the region for Illumina, the world’s leading genome sequencing company. The partners will work together to deliver Illumina’s Next Generation Sequencing (NGS) platform technology to the food safety and microbiology sector in South Korea. NGS is a massively parallel sequencing technology that offers ultra-high throughput, scalability, and speed.  “NGS offers an unprecedented opportunity to the food market to improve safety, We are delighted to partner with Sanigen whose…

READ MORE